One recent study suggests that the highly-expressed BCAT1 in blast crisis chronic myeloid leukemia (BC-CML) re-amidate BCKA into BCAA, thus promoting the mTOR signaling pathway and the progress of BC-CML (34). The gene discussed is ARID4B; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.